JEAN WALLNER: Open Payments
NPI 1639220973 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,581 in 40 payments from 12 companies in 2025. Trend: 2023 $1,394 · 2024 $1,711 · 2025 $4,581
Consulting: $2,423Food & beverage: $1,305Travel & lodging: $854
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $3,616 |
| Amgen Inc. | 13 | $433 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $193 |
| Regeneron Pharmaceuticals, Inc. | 1 | $101 |
| Novo Nordisk Inc | 2 | $49 |
| PFIZER INC. | 2 | $44 |
| Chiesi USA, Inc. | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $39 |
| AtriCure, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: EVKEEZA, REPATHA, Kerendia, Wegovy, JUXTAPID, PRALUENT, ONPATTRO, VYNDAQEL.
Industry payments across FL — which companies pay providers there.
